Zenrise Clinical Research Private Limited, a active private limited company, was established on 20 July 2017 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U73100TG2017PTC118411. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹7.57 Cr and a paid-up capital of ₹5.43 Cr.
It upholds a compliant status. Employing 148 professional, Its leadership includes Akula Indira Prasanna (Whole-Time Director), Srinivas Ravuri (Director), Loganathan Sekar (Director). Past directors included Akula Indira Prasanna, Loganathan Sekar, Rajesh Suvvaru Kumar. It holds ₹11.40 Cr open charges and ₹9.40 Cr settled loans. Its latest AGM occurred on 27 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 201, Mythri Nagar, Madinauda, Miyapur,, Hyderabad, Telangana, 500050.
U73100TG2017PTC118411
118411
20 July 2017
₹7.57 Cr
₹5.43 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Zenrise Clinical Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Akula Indira Prasanna | Whole-Time Director | 19 Mar 2018 | Current |
| Srinivas Ravuri | Director | 20 Jul 2017 | Current |
| Loganathan Sekar | Director | 29 Jan 2024 | Current |
| Akula Thukaram Bapuji | Ceo | 11 Jul 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 24 Jul 2018 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2024 | Past |
| Pramod Abcsdd | Director | 24 Jul 2018 | Past |
| Pramod Abcsdd | Additional Director | 19 Dec 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Zenrise Clinical Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.03% increase. The company also saw a slight decrease in profitability, with a 8.74% decrease in profit. The company's net worth Soared by an impressive increase of 47.57%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Zenrise Clinical Research had a promoter holding of 85.93% and a public holding of 14.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹114,000,000.00
₹94,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Oct 2023 | Others | ₹11.40 Cr | Open |
| 13 Aug 2021 | State Bank Of India | ₹1.40 Cr | Satisfied |
| 25 Jan 2019 | Others | ₹8.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Zenrise Clinical Research has a workforce of 148 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Zenrise Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenrise Clinical Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 25 Jan 2019 via Charge ID 100233725 with Others was fully satisfied on 21 Jan 2025. was recorded as a recent event.
Progress on Zenrise Clinical Research Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records. was documented.
Progress on Zenrise Clinical Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
The activity Loganathan Sekar was appointed as a Director was appointed as a Director on 29 Jan 2024 & has been associated with this company since 1 year 10 months . was completed.
Progress on A charge with Others amounted to Rs. 11.40 Cr with Charge ID 100798470 was registered on 21 Oct 2023. was documented.
A charge registered on 13 Aug 2021 via Charge ID 100486175 with State Bank Of India was fully satisfied on 11 Jul 2023. was recorded as a recent event.
The CIN of Zenrise Clinical Research Private Limited is U73100TG2017PTC118411.
Zenrise Clinical Research Private Limited is headquartered at Plot No. 201, Mythri Nagar, Madinauda, Miyapur,, Hyderabad, Telangana, 500050.
Zenrise Clinical Research Private Limited was incorporated on 20 July 2017.
The current directors of Zenrise Clinical Research Private Limited are
The primary industry of Zenrise Clinical Research Private Limited is Professional, Scientific And Technical.
Zenrise Clinical Research Private Limited is unlisted.
The authorized capital of Zenrise Clinical Research Private Limited is ₹7.57 Cr, and the paid-up capital is ₹5.43 Cr.
The compliance status of Zenrise Clinical Research Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX